Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion.
Zarei M, Du H, Nassar AH, Yan RE, Giannikou K, Johnson SH, Lam HC, Henske EP, Wang Y, Zhang T, Asara J, Kwiatkowski DJ.
Zarei M, et al. Among authors: henske ep.
J Exp Med. 2019 Nov 4;216(11):2635-2652. doi: 10.1084/jem.20190251. Epub 2019 Sep 10.
J Exp Med. 2019.
PMID: 31506280
Free PMC article.